SUNSHINE PHARMA (06887) intends to repurchase company shares.
Dongyang Guangyao (06887) announces that the company intends to repurchase its own shares on the open market. The management of the company is optimistic about the group...
SUNSHINE PHARMA (06887) announced that the company intends to repurchase its own shares on the open market. The management team is confident in the future prospects of the group, and the proposed buyback reflects the board and management team's confidence in the long-term business prospects and development of the company. The board believes that the proposed buyback is in the best interests of the company and its shareholders overall.
Related Articles
LEADS BIOLABS-B (09887) recommends adopting an H-share reward plan.
US Stock Market Move | Q3 performance exceeds expectations, Kohl's Department Store (KSS.US) soars over 30%.
ACESO LIFE SCI (00474) announced that it is expected to achieve a profit of approximately HK$380 million in the middle of the year, reversing from a loss to a profit compared to the same period last year.
LEADS BIOLABS-B (09887) recommends adopting an H-share reward plan.
US Stock Market Move | Q3 performance exceeds expectations, Kohl's Department Store (KSS.US) soars over 30%.
ACESO LIFE SCI (00474) announced that it is expected to achieve a profit of approximately HK$380 million in the middle of the year, reversing from a loss to a profit compared to the same period last year.
RECOMMEND
Foreign Brands “Take On Chinese Names”: Starbucks And Burger King Change Hands As Chinese Capital’s Localization Scalpel Rewrites Global Rules
25/11/2025
Riding The Momentum Of Gemini 3, “Google Chain” Challenges “Nvidia Chain,” Reshaping The Ai Trading Landscape
25/11/2025
Silver Economy Accelerates As Personal Pension System Marks Three Years — Structural Changes Emerging
25/11/2025
